DELIVERY ORDER
Active75N93026F00002
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH NIAID
$1.4M
obligated · signed 3 months ago
SCREENING CANDIDATE COUNTERMEASURES FOR VIRAL HEMORRHAGIC FEVER USING LIVER-BASED ORGAN-ON-A-CHIP MICROPHYSIOLOGICAL SYSTEMS (MPS) IN HIGH-LEVEL CONTAINMENT
Performance timeline
Start
Jul 27, 2026
End
Jul 26, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Jul 26, 2027
UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
Contract 75N93026F00002
UEI
MSPWVMXXMN76
Parent Company
UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
Capabilities & Certifications
Headquarters Location
Congressional District: 14
Current Obligation
$1,388,934
Base + Exercised Options
$1,388,934
Total Ceiling Value
$6,285,771
Contract Type
COST NO FEE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Place of Performance
Congressional District: 14
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office
Contract Vehicle
75N93024D00042
IDCDepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.